Summary
Type-specific antigens for herpes simplex virus type 1 and 2 were prepared by rigorous absorption of cell extracts with heterotypic immune sera. Type-specificity was demonstrated by immunodiffusion and complement-fixation tests against immune sera prepared in rabbits. Specific type 1 complement-fixing reactivity was detected in eleven of fifteen sera from Roman Catholic nuns and in two convalescent sera from patients with recurrent herpes labialis; these sera had been previously shown to contain neutralising and complement-fixing antibody to herpes simplex virus. Three of the non-reacting sera contained low or absent levels of type-common complement-fixing reactivity and the other contained no type-specific neutralising antibody. With the exception of three “acute“ sera, specific type 2 complement-fixing reactivity was detected in every convalescent or interim serum obtained from patients with a virologically-proven history of type 2 herpes virus infection. It is suggested that complement-fixation testing using these absorbed type-specific antigens preparations may provide a convenient and rapid method for the identification of type-specific antibody in human sera.
Similar content being viewed by others
References
Schneweis, K. E.: Serologische Untersuchungen zur Typendifferenzierung des Herpesvirus hominis. Z. Immun. Forsch.124, 24–48 (1962).
Dowdle, W. R., Nahmias, A. J., Harwell, R. W., Pauls, F. P.: Association of antigenic types of herpesvirus hominis with site of viral recovery. J. Immunol.99, 974–980 (1967).
Plummer, G., Goodheart, G. R., Miyagi, M., Skinner, G. R. B., Thouless, M. E., Wildy, P.: Herpes simplex viruses: Discrimination of types and correlation between different characteristics. Virology60, 206–216 (1974).
Naib, Z. M., Nahmias, A. J., Josey, W. E., Kramer, J. H.: Genital herpetic infection associated with cervical dysplasia and carcinoma. Cancer23, 940–945 (1969).
Rawls, W. E., Tompkins, W. A. F., Figueroa, M., Melnick, J. L.: Herpesvirus type 2: Association with carcinoma of the cervix. Science161, 1255–1256 (1968).
Skinner, G. R. B., Thouless, M. E., Jordan, J. A.: Antibodies to type 1 and type 2 herpes virus in women with abnormal cervical cytology. J. Obstet. Gynaec. Brit. Commonwealth78, 1031–1038 (1971).
Vestergaard, B. F., Hornsleth, A., Pedersen, S. N.: Occurrence of herpes and adenovirus antibodies in patients with carcinoma of the cervix eutri. Measurement of antibodies toHerpesvirus hominis (types 1 and 2). Cancer30, 68–74 (1972).
Adam, E., Kaufman, R. H., Melnick, J. L., Levy, A. H., Rawls, W. E.: Seroepidemiologic studies of herpes virus type 2 and carcinoma of the cervix IX. Dysplasia and carcinomain situ. Amer. J. Epidemiol.98, 77–87 (1973).
Nahmias, A. J., Josey, W. E., Naib, Z. M., Luce, C. F., Duffey, A.: Antibodies toherpesvirus hominis types 1 and 2 in humans. 1. Patients with genital herpetic infection. 2. Women with cervical cancer. Amer. J. Epidemiol.91, 539–546 (1970).
Aurelian, L., Royston, L., Davis, H. J.: Antibody to genital herpes simplex virus: Association with cervical atypia and carcinomain situ. J. Natl. Cancer Inst.45, 455–463 (1970).
Rawls, W. E., Tompkins, W. A. F., Melnick, J. L.: The association of herpesvirus type 2 and carcinoma of the uterine cervix. Amer. J. Epidemiol.89, 547–554 (1969).
Wildy, P.: Herpesvirus and Antigens. In:Biggs, P. M., Thé, G. de, Payne, G. L. (eds.), Oncogenesis and Herpesviruses, 409–419. Lyon: International Agency for Research on Cancer 1972.
Skinner, G. R. B., Taylor, J., Edwards, J.: Precipitating antibodies to herpes simplex virus in human sera: Prevalence of antibody to common antigen (Band II). Intervirology, in press (1975).
Skinner, G. R. B., Thouless, M. E., Trueman, S., Edwards, J., Gibbs, A. J.: Serorelatedness of herpes simplex viruses: type-specificity of antibody response. J. Immunol., submitted for publication (1976).
Nahmias, A. J., Dowdle, W. R., Kramer, J. L., Luce, C. F., Mansour, S. C.: Antibodies to herpesvirus hominis types 1 and 2 in the rabbit. J. Immunol.102, 956–962 (1969).
Thouless, M. E.: Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus. J. gen. Virol.17, 307–315 (1972).
Sim, C., Watson, D. H.: The role of type-specific and cross-reacting structural antigens in the neutralisation of herpes simplex virus types 1 and 2. J. gen. Virol.19, 217–233 (1973).
Rawls, W. E., Cashon, G., Adam, E., Ogino, T., Duff, R., Rapp, R.: Herpes virus type 2-induced thymidine kinase and carcinoma of the cervix. Cancer Res.34, 362–366 (1974).
Wildy, P.: Recombination with herpes simplex virus. J. gen. Microbiol.13, 346–360 (1955).
Geder, L., Skinner, G. R. B.: Differentiation between type 1 and type 2 strains of herpes simplex virus by an indirect immunofluorescent technique. J. gen. Virol.12, 179–182 (1971).
Beale, A. J., Christofinis, G. C., Furminger, J. C. S.: Rabbit cells susceptible to rubella virus. Lancetii, 640–641 (1963).
MacPherson, I., Stoker, M.: Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence. Virology16, 147–151 (1962).
Watson, D. H., Sheddon, W. I. H., Elliot, A., Tetsuka, T., Wildy, P., Bourgaux-Ramoisy, D., Gold, E.: Virus specific antigens in mammalian cells infected with herpes simplex virus. Immunology11, 399–408 (1966).
Watson, D. H.: The separation of herpes virus specific antigens by polyacrylamide gel electrophoresis. J. gen. Virol.4, 151–161 (1969).
Skinner, G. R. B.: M. D. Thesis, University of Birmingham, 1975.
Author information
Authors and Affiliations
Additional information
With 1 Figure
Rights and permissions
About this article
Cite this article
Skinner, G.R.B., Hartley, C. & Whitney, J.E. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests. Archives of Virology 50, 323–333 (1976). https://doi.org/10.1007/BF01317957
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317957